Hypercortisolism
Showing 1 - 25 of 82
Hypercortisolism, Diabetes, Type 2 Trial (Mifepristone 300 MG [Korlym], Placebo for mifepristone)
Not yet recruiting
- Hypercortisolism
- Diabetes Mellitus, Type 2
- Mifepristone 300 MG [Korlym]
- Placebo for mifepristone
- (no location specified)
Mar 6, 2023
Adrenal Tumour With Mild Hypercortisolism Trial in Denmark, Norway, Sweden (Adrenalectomy)
Recruiting
- Adrenal Tumour With Mild Hypercortisolism
- Adrenalectomy
-
Århus, Denmark
- +3 more
Jan 11, 2023
Adrenal Incidentaloma, Subclinical Hypercortisolism Trial in Nanjing (experimental group)
Recruiting
- Adrenal Incidentaloma
- Subclinical Hypercortisolism
- experimental group
-
Nanjing, Jiangsu, Chinaat Divison of Endocrinology,the Affiliated Drum Tower Hospital o
Apr 14, 2022
Effects of Metyrapone in Patients With Hypercortisolism
Recruiting
- Hypercortisolism
- Metyrapone Capsules
-
Milano, ItalyIstituto Auxologico Italiano
May 18, 2022
Cortisol Secretion, Sensitivity and Activity and Hypertension
Recruiting
- Hypercortisolism
- Arterial Hypertension
- Dexamethasone suppression test
-
Milan, MI, ItalyIstituto Auxologico Italiano IRCCS
Mar 10, 2023
Adult Glucocorticoid Excess, Adult Adrenal Insufficiency Trial (Biological samples, Complications)
Not yet recruiting
- Adult Glucocorticoid Excess
- Adult Adrenal Insufficiency
- Biological samples
- Complications
- (no location specified)
Dec 20, 2021
Prevalence of Hidden Hypercortisolism in Osteoporosis
Recruiting
- Osteoporosis
- Cortisol Excess
-
Catania, Italy
- +4 more
Mar 8, 2023
Autonomous Cortisol Secretion (ACS), ACTH-Independent Cushing Syndrome, ACTH-Independent Adrenal Cushing Syndrome, Somatic Trial
Recruiting
- Autonomous Cortisol Secretion (ACS)
- +2 more
- SPI-62 dose1
- +4 more
-
Los Angeles, California
- +45 more
Jul 13, 2022
Novel Mediators of Lipodystrophy and Metabolic Consequences of
Completed
- Cushing's Syndrome
- Treatment of Cushing's
-
New York, New YorkColumbia University Neuroendocrine Unit
Jul 12, 2021
Adrenal Incidentaloma, Subclinical Hypercortisolism Trial (adrenalectomy)
Active, not recruiting
- Adrenal Incidentaloma
- Subclinical Hypercortisolism
- adrenalectomy
- (no location specified)
Apr 22, 2021
Type 2 Diabetes, Obesity and Cortisol Excess
Recruiting
- Diabetes Mellitus, Type 2
- +2 more
- 1mg DST
-
Milan, ItalyIstituto Auxologico Italiano
Mar 9, 2023
Cushing Syndrome, Fatty Liver Disease Trial (hepatic MRI)
Not yet recruiting
- Cushing Syndrome
- Fatty Liver Disease
- hepatic MRI
- (no location specified)
May 25, 2023
Cushing Disease Trial in France (Patient group, Remission control group, Bilateral surrenalectomy control group)
Recruiting
- Cushing Disease
- Patient group
- +2 more
-
Caen, France
- +6 more
Dec 16, 2021
1 mg DST in Patients With Chronic Renal Failure
Completed
- Cushing Syndrome
- Dexamethasone suppression test
-
Istanbul, Pendik, TurkeyÖzlem ÜSTAY
Oct 2, 2022
Adrenal IncidenTalomas and Possible Autonomous Cortisol
Recruiting
- Adrenal Incidentaloma
- +2 more
- Adrenalectomy
-
Rome, ItalyDepartment of Experimental Medicine
Oct 11, 2019
Defining Genetic Basis for Development of Primary Pigmented
Completed
- Cushing's Syndrome
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2023
Cushing Syndrome, Hypercortisolism Trial in Umeå (Liqourice)
Unknown status
- Cushing Syndrome
- Hypercortisolism
- Liqourice
-
Umeå, SwedenDepartment of Public Health and Clinical, Umeå University
Aug 1, 2019
Pediatric Patients Treated With Korlym for Cushing Syndrome
Terminated
- Hypercortisolism
- Cushing Syndrome
-
Menlo Park, CaliforniaCorcept Therapeutics
Jul 26, 2019
Adrenal and Other Endocrine Tumors in Patients With Sudden Death
Recruiting
- Primary Aldosteronism
- +3 more
- Adrenal aldosterone synthase (CYP11B2) staining
- +2 more
-
Helsinki, FinlandEndocrinology, Helsinki University Hospital and University of He
Jul 8, 2022
Adults With Endocrine and Metabolic-Related Conditions
Recruiting
- Endocrine Diseases
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 18, 2022
Adrenal Insufficiency, Polymyalgia Rheumatica, Giant Cell Arteritis Trial in Aarhus, Copenhagen, Odense (Hydrocortisone, Placebo
Recruiting
- Adrenal Insufficiency
- +2 more
- Hydrocortisone
- Placebo for hydrocortisone
-
Aarhus, Denmark
- +2 more
Jun 23, 2022
Study of Adrenal Gland Tumors
Completed
- Adrenal Gland Neoplasm
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Improved Diagnostics and Monitoring of Polymyalgia Rheumatica
Recruiting
- Polymyalgia Rheumatica
- +2 more
- PET/CT
-
Aarhus, Denmark
- +2 more
Dec 10, 2021
Glucocorticoid Withdrawal Syndrome in Treated Cushing Syndrome
Recruiting
- Cushing Syndrome
- MUSE biofeedback
-
Rochester, MinnesotaMayo Clinic
Oct 31, 2022